LP

Laurence Patterson

BL Biostatus Limited: 9 patents #1 of 7Top 15%
IN Incanthera: 5 patents #3 of 11Top 30%
BI Btg International: 2 patents #68 of 310Top 25%
BL British Technology Group Limited: 2 patents #66 of 501Top 15%
UB University Of Bradford: 2 patents #4 of 36Top 15%
ND National Research Development: 1 patents #307 of 1,071Top 30%
TL The School Of Pharmacy, University Of London: 1 patents #2 of 20Top 10%
Overall (All Time): #130,488 of 4,157,543Top 4%
29
Patents All Time

Issued Patents All Time

Showing 1–25 of 29 patents

Patent #TitleCo-InventorsDate
11447638 Acetalanthraquinone derivatives useful for cellular staining Paul James Smith, Rachel Jane Errington, Klaus Pors, Laura Cosentino 2022-09-20
11401234 Deuterated compounds and uses thereof Stefan Ogrodzinski, Paul James Smith, Stephanie McKeown, Rachel Jane Errington 2022-08-02
11266613 Lidocaine n-oxide for use in the prophylaxis of sudden cardiac death 2022-03-08
11255761 Method of analysing a cell or other biological material containing a nucleic acid Paul James Smith, Rachel Jane Errington 2022-02-22
10912839 Methods of treating cancer using compounds containing a vascular disrupting agent Robert Falconer, Jason Gill, Jennifer Xavier, Paul Loadman, Michael Bibby 2021-02-09
10556014 Compounds containing a vascular disrupting agent Jason Gill, Paul Loadman, Rob Falconer, Jennifer Xavier, Michael Bibby 2020-02-11
10385009 Deuterated compounds and uses thereof Stefan Ogrodzinski, Paul James Smith, Stephanie McKeown, Rachel Jane Errington 2019-08-20
9956296 Compounds containing a vascular disrupting agent Jason Gill, Paul Loadman, Rob Falconer, Jennifer Xavier, Michael Bibby 2018-05-01
9937267 Methods of treating cancer using compounds containing a vascular disrupting agent Robert Falconer, Jason Gill, Jennifer Xavier, Paul Loadman, Michael Bibby 2018-04-10
9759715 Gel formulations and uses thereof Paul James Smith, Rachel Jane Errington 2017-09-12
9358303 Compounds containing a vascular disrupting agent Jason Gill, Paul Loadman, Rob Falconer, Jennifer Xavier, Michael Bibby 2016-06-07
9051467 Method of analysing a cell or other biological material containing a nucleic acid Paul James Smith, Rachel Jane Errington 2015-06-09
8927486 Compounds Robert Falconer, Jason Gill, Jennifer Atkinson, Paul Loadman, Michael Bibby 2015-01-06
8691751 Compounds containing a vascular disrupting agent Jason Gill, Paul Loadman, Rob Falconer, Jennifer Atkinson, Mike Bibby 2014-04-08
8017640 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment Mark Searcey 2011-09-13
7723085 Analyzing cells immobilized in block copolymers Paul James Smith, Rachel Jane Errington 2010-05-25
7626026 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment Mark Searcey 2009-12-01
7605280 Anthraquinone and its derivatives Paul James Smith 2009-10-20
7557215 Anthraquinone compounds as anti cancer compounds Klaus Pors, Paul Henry Teesdale-Spittle 2009-07-07
7276537 Formulations of anthraquinone derivatives William Alexander Denny, Gavin Halbert, Steven Ford 2007-10-02
7192977 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment Mark Searcey 2007-03-20
7179921 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment Mark Searcey 2007-02-20
7074835 Formulations of anthraquinone derivatives William Alexander Denny, Gavin Halbert, Steven Ford 2006-07-11
7060427 Anthraquinone and its derivatives Paul James Smith 2006-06-13
6468753 Anthraquinone and its derivatives Paul James Smith 2002-10-22